ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs operating margin
Operating margin is operating income as a percentage of revenue.
ProPhase Labs's operating margin for the twelve months ending Jun 30, 2026 was -404.5%. For fiscal 2025 it was -415.4%, against -570.6% the year before. The highest annual figure on record is 19.2% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -415.4% | +155.2 |
| FY2024 | Dec 31, 2024 | -570.6% | −509.9 |
| FY2023 | Dec 31, 2023 | -60.7% | −79.9 |
| FY2022 | Dec 31, 2022 | 19.2% | +6.8 |
| FY2021 | Dec 31, 2021 | 12.4% | +26.7 |
| FY2020 | Dec 31, 2020 | -14.3% | +18.5 |
| FY2019 | Dec 31, 2019 | -32.8% | −20.3 |
| FY2018 | Dec 31, 2018 | -12.4% | +28.0 |
| FY2017 | Dec 31, 2017 | -40.4% | +22.7 |
| FY2016 | Dec 31, 2016 | -63.1% | +79.2 |
| FY2015 | Dec 31, 2015 | -142.3% | −106.9 |
| FY2014 | Dec 31, 2014 | -35.5% | −37.1 |
| FY2013 | Dec 31, 2013 | 1.7% | +6.6 |
| FY2012 | Dec 31, 2012 | -4.9% | +10.8 |
| FY2011 | Dec 31, 2011 | -15.7% | +9.1 |
| FY2010 | Dec 31, 2010 | -24.8% | −4.9 |
| FY2009 | Dec 31, 2009 | -19.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -261.6% | +50.6 |
| Q1 FY2026 | Mar 31, 2026 | -207.5% | +48.4 |
| Q4 FY2025 | Dec 31, 2025 | -730.4% | +426.9 |
| Q3 FY2025 | Sep 30, 2025 | -539.5% | −81.9 |
| Q2 FY2025 | Jun 30, 2025 | -312.3% | +168.3 |
| Q1 FY2025 | Mar 31, 2025 | -256.0% | +67.9 |
| Q4 FY2024 | Dec 31, 2024 | -1157.3% | −844.1 |
| Q3 FY2024 | Sep 30, 2024 | -457.6% | −380.2 |
| Q2 FY2024 | Jun 30, 2024 | -480.6% | −445.3 |
| Q1 FY2024 | Mar 31, 2024 | -323.9% | −328.4 |
| Q4 FY2023 | Dec 31, 2023 | -313.2% | −289.9 |
| Q3 FY2023 | Sep 30, 2023 | -77.4% | −85.5 |
| Q2 FY2023 | Jun 30, 2023 | -35.2% | −71.6 |
| Q1 FY2023 | Mar 31, 2023 | 4.5% | −29.4 |
| Q4 FY2022 | Dec 31, 2022 | -23.3% | −53.6 |
| Q3 FY2022 | Sep 30, 2022 | 8.1% | +46.5 |
| Q2 FY2022 | Jun 30, 2022 | 36.4% | +52.3 |
| Q1 FY2022 | Mar 31, 2022 | 34.0% | +26.0 |
| Q4 FY2021 | Dec 31, 2021 | 30.3% | +45.0 |
| Q3 FY2021 | Sep 30, 2021 | -38.4% | −23.6 |
| Q2 FY2021 | Jun 30, 2021 | -15.9% | −17.6 |
| Q1 FY2021 | Mar 31, 2021 | 8.0% | +51.0 |
| Q4 FY2020 | Dec 31, 2020 | -14.7% | +0.1 |
| Q3 FY2020 | Sep 30, 2020 | -14.8% | +1.9 |
| Q2 FY2020 | Jun 30, 2020 | 1.6% | +78.4 |
| Q1 FY2020 | Mar 31, 2020 | -43.0% | +2.0 |
| Q4 FY2019 | Dec 31, 2019 | -14.8% | −4.9 |
| Q3 FY2019 | Sep 30, 2019 | -16.7% | +20.7 |
| Q2 FY2019 | Jun 30, 2019 | -76.8% | −68.5 |
| Q1 FY2019 | Mar 31, 2019 | -45.0% | −43.5 |
| Q4 FY2018 | Dec 31, 2018 | -9.9% | −1.9 |
| Q3 FY2018 | Sep 30, 2018 | -37.4% | −7.7 |
| Q2 FY2018 | Jun 30, 2018 | -8.3% | +38.2 |
| Q1 FY2018 | Mar 31, 2018 | -1.6% | +95.1 |
| Q4 FY2017 | Dec 31, 2017 | -8.0% | −107.2 |
| Q3 FY2017 | Sep 30, 2017 | -29.7% | +26.4 |
| Q2 FY2017 | Jun 30, 2017 | -46.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -96.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 99.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -56.1% | – |
See a number that looks wrong?